Next-generation Cologuard Test Demonstrates 94 Percent Sensitivity for Colorectal Cancer at 91 Percent Specificity, Raising the Bar in Non-invasive Screening (PRNewswire)

The article discusses the effectiveness of the next-generation Cologuard test in non-invasive screening for colorectal cancer. According to the findings, the test demonstrated a sensitivity of 94% for detecting colorectal cancer with a specificity of 91%. Sensitivity refers to the test’s ability to correctly identify individuals who have colorectal cancer, while specificity refers to its ability to correctly identify individuals who do not have the disease.